Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine, today announced that ten abstracts have been accepted for presentation at the 2025 San Antonio Breast ...
Citius Oncology, Inc. ("Citius Oncology" or the "Company") , the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") , today announced that it has entered into a definitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback